Thursday, February 2, 2023

Tag: Lisa Cosgrove

Researchers Challenge Industry-Friendly Depression Guideline

13
Review of a new mixed depression guideline reveals financial bias of guideline developers and lack of evidence supporting recommendations for prescribing of antipsychotics.

Why Disclosure Policies Don’t Discourage Drug Salesmen

2
From The Chronicle: The practice of pharmaceutical industry payments to academic researchers to help promote their drugs remains widespread. Requiring scientists to disclose their ties...

“You Could Be Paying More for Less Effective Medicine”

0
A new study by Lisa Cosgrove, "Under the Influence: The Interplay among Industry, Publishing, and Drug Regulation," suggests that weak drug regulation can lead...

Undisclosed Financial Conflicts Endemic in Clinical Practice Guidelines

11
While there has been a recent push to account for financial conflicts of interest in medical research, less attention has been paid to organizations...

Latest Antidepressant a Case Study in Institutional Corruption

7
A new study tracks the approval of the latest antidepressant, vortioxetine, by the Federal Drug Administration (FDA) and the European Medicines Agency (EMA). The...

 The “Institutional Corruption” of Psychiatry: A Conversation With Authors...

1
Robert Whitaker and Lisa Cosgrove discuss their new book Psychiatry Under the Influence in an interview with psychologist and social critic Bruce Levine for Truthout. In the book, Whitaker and Cosgrove apply the institutional corruption framework, developed by Larry Lessig, to psychiatry and determine that “just as elected officials develop dependency on special interests and become beholden to these funders instead of the citizenry,” psychiatry has “had its social mission subverted by drug companies as well as by the psychiatry guild's self-preservation and expansionism needs.”